3 stellar growth shares I would buy this week

Bellamy's Australia Ltd (ASX:BAL) shares are one of three that I think growth investors should look closely at this week…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I believe that the Australian share market is home to a great number of quality growth shares for investors to choose from.

Three quality growth shares that are at the top of my list right now are listed below.

Here's why I think investors ought to consider buying them this week:

Aristocrat Leisure Limited (ASX: ALL)

Over the last decade this gaming technology company's shares have provided an average annual total return of almost 15%. Thanks to its market leadership in the pokie machine space and its fledgling mobile and social gaming business, I believe there's a good chance that these market-beating returns will continue over the next few years. This could make it a great option for investors today, especially as its shares are changing hands at just 23x estimated full year earnings.

Bellamy's Australia Ltd (ASX: BAL)

This infant formula company's shares have been on a tear over the last 12 months and risen an incredible 302%. Although this impressive gain has left them trading at a significant premium to the market average, one leading broker believes there is still meaningful upside left in the tank over the next 12 months. Thanks to strong demand in China and its belief that Bellamy's will be able to lift the price of its products, Goldman Sachs has a $25.70 price target on Bellamy's shares.

Cochlear Limited (ASX: COH)

The global population is getting older and few companies stand to benefit as much as this hearing solutions company in my opinion. This is because as people age, generally their hearing will become impaired. I expect this will lead to growing demand for Cochlear's high quality products for many years to come, putting it in a position to continue delivering above average profit growth in the future.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »